Cargando…
(18)F-AzaFol for Detection of Folate Receptor-β Positive Macrophages in Experimental Interstitial Lung Disease—A Proof-of-Concept Study
Background: Interstitial lung disease (ILD) is a common and severe complication in rheumatic diseases. Folate receptor-β is expressed on activated, but not resting macrophages which play a key role in dysregulated tissue repair including ILD. We therefore aimed to pre-clinically evaluate the potenti...
Autores principales: | Schniering, Janine, Benešová, Martina, Brunner, Matthias, Haller, Stephanie, Cohrs, Susan, Frauenfelder, Thomas, Vrugt, Bart, Feghali-Bostwick, Carol, Schibli, Roger, Distler, Oliver, Müller, Cristina, Maurer, Britta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883947/ https://www.ncbi.nlm.nih.gov/pubmed/31824505 http://dx.doi.org/10.3389/fimmu.2019.02724 |
Ejemplares similares
-
Radiation dosimetry of (18)F-AzaFol: A first in-human use of a folate receptor PET tracer
por: Gnesin, Silvano, et al.
Publicado: (2020) -
Evaluation of (99m)Tc-rhAnnexin V-128 SPECT/CT as a diagnostic tool for early stages of interstitial lung disease associated with systemic sclerosis
por: Schniering, Janine, et al.
Publicado: (2018) -
Folate Augmentation of Treatment – Evaluation for Depression (FolATED): protocol of a randomised controlled trial
por: Roberts, Seren Haf, et al.
Publicado: (2007) -
Transferability of radiomic signatures from experimental to human interstitial lung disease
por: Gabryś, Hubert S., et al.
Publicado: (2022) -
Applicability of radiomics in interstitial lung disease associated with systemic sclerosis: proof of concept
por: Martini, K., et al.
Publicado: (2020)